Protective effect of Hypericum hircinum on doxorubicin-induced cardiotoxicity in rats

Natural Product Research

Volumn 27, Issue 16, 2013, Pages 1502-1507

  Shah, Sudeep ^a   Mohan, Mahalaxmi ^a   Kasture, Sanjay ^a,c   Ballero, Mauro ^b,d   Maxia, Andrea ^b,c   Sannabd, Cinzia ^d  

^a MGV's Pharmacy College   (India)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Applied Plant Research International Network   (Italy)

^d Consorzio Interuniversitario per Lo Studio Dei Metaboliti Secondari ^*  (Italy)

Author keywords

Antioxidant defence enzyme; Cardiac marker enzymes; Doxorubicin; H. hircinum

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; DOXORUBICIN; GLUTATHIONE; HYPERICUM HIRCINUM EXTRACT; LACTATE DEHYDROGENASE; LIPID PEROXIDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART PROTECTION; HEART RATE; HEART WEIGHT; NONHUMAN; OXIDATIVE STRESS; QRS COMPLEX; QT INTERVAL; ST SEGMENT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; DOXORUBICIN; ELECTROCARDIOGRAPHY; GLUTATHIONE; HEART; HYPERICUM; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84884238592     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2012.724409     Document Type: Article

References (19)

1. Bachur, N.R., Gordon, S.L., Gee, M.V., &Kon, H. (1979). NADPH-cytochrome P450 reductase activation of quinone anticancer agents to free radicals. Proceedings of the National Academy of Sciences of the Unites States of America, 76, 954-957.
2. Calabresi, P., &Chabner, B.A. (1990). Chemotherapy of neoplastic diseases. In A.G. Gilman, T.W. Rall, A.S. Nies, &P. Taylor (Eds.), The pharmacological basis of therapeutics (pp. 1203-1263). New York: Pergamon Press.
3. Cecchini, C., Cresci, A., Coman, M.M., Ricciutelli, M., Sagratini, G., Vittori, S., . . . Maggi, F. (2007). Antimicrobial activity of seven Hypericum entities from Central Italy. Planta Medica, 73, 564-566.
4. de Costerd, L., Stoeckli-Evans, H., Msonthi, J.D., &Hostettmann, K. (1987). New antifungal chromenyl ketones and their pentacyclic dimers from Hypericum revolutum. Helvetica Chimica Acta, 70, 1694-1702.
5. Goormaghtigh, E., &Ruysschaert, J.M. (1984). Anthracycline glycosides-membrane interactions. Biochimie et Biophysica Acta, 779, 271-288.
6. Haenen, G.R.M.M., Janssen, F.P., &Bast, A. (1993). The antioxidant properties of five (O- hydroxyethyl) rutosides of the flavonoid mixture Venoruton. Phlebology, Supplement, 1, 10-17.
7. Ishiguro, K., Yamaki, M., Kashihara, T., Takagi, S., &Isoi, K.A. (1990). New antimicrobial compound from Hypericum japonicum. Planta Medica, 56, 274-276.
8. Jayasuriya, K., Mechesney, J.D., Swanson, S.M., &Pezzuto, J.M. (1989). Antimicrobial and cytotoxic activity of rottlerin type compounds from Hypericum drummondii. Journal of Natural Products, 52, 325-331.
9. Jensen, R.A., Acton, E.M., &Peters, J.H. (1984). Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects. Journal of Cardiovascular Pharmacology, 6, 186-200.
10. Lee, V., Randhawa, A.K., &Singhal, P.K. (1991). Adriamycin induced myocardial dysfunction in vitro is mediated by free radicals. American Journal of Physiology, 261, H989-H995.
11. Myers, C.E., Mcguire, W.P., Liss, R.H., Ifrim, I., Grotzinger, K., &Young, R.C. (1977). Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science, 19, 165-167.
12. Nohl, H., Gille, L., &Stanick, K. (1998). The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines. Zeitschrift für Naturforschung-C, 53, 279-285.
13. Olson, R.D., &Mushlin, P.S. (1990). Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB Journal, 4, 3076-3086.
14. Pieroni, A., Quave, C.L., &Santoro, R.F. (2004). Folk pharmaceutical knowledge in the territory of the DolomitiLucane, inland southern Italy. Journal of Ethnopharmacology, 95, 373-384.
15. Pistelli, L., Bertoli, A., Zucconelli, S., Morelli, I., Panizzi, L., &Menichini, F. (2000). Antimicrobial activity of crude extract and pure compounds of Hypericum hircinum. Fitoterapia, 71, S138-S140.
16. Sagratini, G., Ricciutelli, M., Vittori, S., Ozturk, N., Ozturk, Y., &Maggi, F. (2008). Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia, 79, 210-213.
17. van Acker, S.A., Voest, E.E., Beems, D.B., Madhuizen, H.T., de Jong, J., Bast, A., &van der Vijgh, W.J. (1993). Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxirubcin-pretreated BALB/c mice. Cancer Research, 53, 4603-4607.
18. Von Hoff, D.D., Layard, M.W., Basa, P., Davis, H.L., Von Hoff, A.L., Rozencweig, M., &Muggia, F.M. (1979). Risk factors for doxorubicin induced congestive heart failure. Annals of Internal Medicine, 91, 710-717.
19. Yazaki, K., &Okada, T. (1994). Biotechnology of agricultural forest. In Y.P.S. Bajaja (Ed.), Medicinal and aromatic plants-VI (Vol. 26, pp. 167-169). Berlin: Springer-Verlag.